What is it about?
The aim of this study was to define low- and high-risk groups in terms of survival, and to predict the benefit of adjuvant chemotherapy. We found that adjuvant chemotherapy was not associated with improved survival in patients in the low-risk group identified by a previously published nomogram, whereas it reduced the risk of death by over 20 per cent in the intermediate- and high-risk groups.
Featured Image
Why is it important?
A nomogram can aid in individualized decision-making regarding the administration of adjuvant chemotheraoy after gastrectomy for cancer.
Read the Original
This page is a summary of: Validation of a nomogram for selecting patients for chemotherapy after D2 gastrectomy for cancer, British Journal of Surgery, April 2017, Wiley,
DOI: 10.1002/bjs.10550.
You can read the full text:
Contributors
The following have contributed to this page
